Helen Box
University of Liverpool · 38 works · 1,150 citations · h-index 15
Top works
- Postnatal home visits in teenage mothers: a randomised controlled trial
- FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
- Prioritization of Anti‐SARS‐Cov‐2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics
- Patients' thromboembolic potential after carotid endarterectomy is related to the platelets' sensitivity to adenosine diphosphate
- Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus
- Safety pharmacology — Current and emerging concepts
- Dose prediction for repurposing nitazoxanide in SARS‐CoV‐2 treatment or chemoprophylaxis
- Anticipation of regulatory needs for nanotechnology-enabled health products
- Unexpected medical undergraduate simulation training (UMUST): can unexpected medical simulation scenarios help prepare medical students for the transition to foundation year doctor?
- Pharmacodynamics of Isavuconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis
- Learning health ‘safety’ within non-technical skills interprofessional simulation education: a qualitative study
- Naturally-acquired immunity in Syrian Golden Hamsters provides protection from re-exposure to emerging heterosubtypic SARS-CoV-2 variants B.1.1.7 and B.1.351
- Enhancing health care non‐technical skills: the TINSELS programme
- Non-technical skills learning in healthcare through simulation education: integrating the SECTORS learning model and complexity theory
- Development of a highly sensitive bioanalytical assay for the quantification of favipiravir
- Launching stakeholder discussions on identified regulatory needs for nanotechnology-enabled health products
- Misoprostol-Induced Fever and Genetic Polymorphisms in Drug Transporters SLCO1B1 and ABCC4 in Women of Latin American and European Ancestry
- Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use case
- Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2
- Characterization and Regulation of the Receptor Tyrosine Kinase Tie-1 in Platelets